Cellebrite Di Equity Stock Fundamentals
| CLBTWDelisted Stock | USD 5.15 0.44 7.87% |
Cellebrite DI Equity fundamentals help investors to digest information that contributes to Cellebrite's financial success or failures. It also enables traders to predict the movement of Cellebrite Stock. The fundamental analysis module provides a way to measure Cellebrite's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cellebrite stock.
Cellebrite |
Cellebrite DI Equity Company Operating Margin Analysis
Cellebrite's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Cellebrite Operating Margin | 0.13 % |
Most of Cellebrite's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cellebrite DI Equity is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
CompetitionBased on the recorded statements, Cellebrite DI Equity has an Operating Margin of 0.1305%. This is 99.16% lower than that of the Software sector and significantly higher than that of the Information Technology industry. The operating margin for all United States stocks is 102.37% lower than that of the firm.
Cellebrite DI Equity Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Cellebrite's current stock value. Our valuation model uses many indicators to compare Cellebrite value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cellebrite competition to find correlations between indicators driving Cellebrite's intrinsic value. More Info.Cellebrite DI Equity is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Cellebrite by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Cellebrite Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cellebrite's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cellebrite could also be used in its relative valuation, which is a method of valuing Cellebrite by comparing valuation metrics of similar companies.Cellebrite is currently under evaluation in operating margin category among its peers.
Cellebrite Fundamentals
| Return On Equity | -17.69 | |||
| Return On Asset | 0.0639 | |||
| Profit Margin | (0.29) % | |||
| Operating Margin | 0.13 % | |||
| Number Of Shares Shorted | 356.81 K | |||
| Price To Earning | 12.50 X | |||
| Revenue | 325.11 M | |||
| Gross Profit | 219.91 M | |||
| EBITDA | 43.29 M | |||
| Net Income | (81.1 M) | |||
| Total Debt | 14.13 M | |||
| Book Value Per Share | (0.19) X | |||
| Cash Flow From Operations | 102.06 M | |||
| Earnings Per Share | 0.06 X | |||
| Number Of Employees | 1.01 K | |||
| Beta | 1.52 | |||
| Total Asset | 540.4 M | |||
| Retained Earnings | 118.14 M | |||
| Working Capital | 168.26 M | |||
| Annual Yield | 0.02 % | |||
| Net Asset | 540.4 M |
About Cellebrite Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cellebrite DI Equity's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cellebrite using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cellebrite DI Equity based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Consideration for investing in Cellebrite Stock
If you are still planning to invest in Cellebrite DI Equity check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cellebrite's history and understand the potential risks before investing.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |